Moncyte

Efficient lowering of blood cholesterol is pivotal in reducing the risk for heart attack and stroke, the most frequent causes of death globally. Different cholesterol-lowering drugs are available, but it is difficult to find an optimal treatment strategy for each...
NADMED Oy

NADMED Oy

The biology and key role of NAD molecules in human metabolism has been well known for decades, but measuring them has been devilishly difficult. NADMED has now brought to market an accurate, fast, scalable, and well protected method to do just that. The assay enables...
Karsa Oy

Karsa Oy

The Karsa chemical analysis platform eliminates laborious workflows for the analysis of small molecules. The company wants to bring this approach to the IVD market with analysis of bodily fluids.   Founding year: 2016 Development phase: Proof-of-concept/prototype...
Sonai Health Oy

Sonai Health Oy

Sonai Health develops a new solution for heart diagnosis, utilising patented sensor solution, cloud service and machine learning.   Founding year: 2021 Development phase: Prototype Funding stage: Pre-seed Website: sonai.fi Contact person info:...

Probiont Oy

Probiont is developing personalized solutions for cancer immunotherapy efficacy testing. Our technology is purposed to enable rapid screening of cancer drugs used in immunotherapy, for early identification of effective treatment strategies for individual patients....